Kevin Schutt

Kevin Schutt currently serves as a PD Associate Scientist II at the Center for Breakthrough Medicines since January 2022. Previously, Kevin held the position of Associate Scientist PD at the Janssen Pharmaceutical Companies of Johnson & Johnson from September 2020 to January 2022, and worked as an Assistant Scientist at the same company from May 2019 to December 2019. Kevin's earlier experience includes a role as a Process Scientist at Eurofins Lancaster Laboratories for a brief period in 2020 and an API LM R&D Co-op at Janssen. Kevin completed education at the Rochester Institute of Technology from 2017 to 2020 and attended Elmira College from 2015 to 2017.